• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dianthus Therapeutics, Inc. - Common Stock (NQ:DNTH)

110.40 +4.38 (+4.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dianthus Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
May 12, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September
May 05, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Participate in Two Upcoming Investor Events
April 29, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Forecasting The Future: 5 Analyst Projections For Dianthus Therapeutics ↗
December 20, 2024
 
Via Benzinga
News headline image
Evaluating Dianthus Therapeutics: Insights From 5 Financial Analysts ↗
November 11, 2024
 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Dianthus Therapeutics Through 4 Analysts ↗
November 08, 2024
 
Via Benzinga
News headline image
Friday's pre-market session: top gainers and losers ↗
April 04, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
April 04, 2025
 
Via Benzinga
News headline image
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
March 11, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors
March 05, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Expert Ratings For Dianthus Therapeutics ↗
September 26, 2024
 
Via Benzinga
News headline image
Navigating 4 Analyst Ratings For Dianthus Therapeutics ↗
August 12, 2024
 
Via Benzinga
News headline image
Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
February 26, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences
January 30, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
What 5 Analyst Ratings Have To Say About Dianthus Therapeutics ↗
May 10, 2024
 
Via Benzinga
News headline image
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
November 20, 2024
 
Via Benzinga
News headline image
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
November 07, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
November 04, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting
October 15, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September
September 04, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Ulta Beauty Reports Downbeat Results, Joins Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
August 30, 2024
 
Via Benzinga
News headline image
DNTH Stock Earnings: Dianthus Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
August 09, 2024
DNTH stock results show that Dianthus Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results
August 08, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
June 28, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
June 12, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
DNTH Stock Earnings: Dianthus Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗
May 09, 2024
DNTH stock results show that Dianthus Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
May 09, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
News headline image
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
May 08, 2024
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap